The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors. Led by…
Growth Factors Group
Laboratory tests with mice reveal ‘exciting’ new strategy that could transform triple-negative breast cancer into a manageable disease Researchers at…
The Breast Cancer Research Foundation (BCRF) will commit $60.2 million to breast cancer research in 2023-2024, supporting more than 250…
Redirection of lymphocytes, via T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), is already approved to treat some hematologic…
